205 related articles for article (PubMed ID: 17455300)
21. Physical stability of crystal hydrates and their anhydrates in the presence of excipients.
Salameh AK; Taylor LS
J Pharm Sci; 2006 Feb; 95(2):446-61. PubMed ID: 16380975
[TBL] [Abstract][Full Text] [Related]
22. Investigation of the phase transitions occurring during and after the dehydration of xylazine hydrochloride monohydrate.
Krūkle-Bērziņa K; Actiņš A
Int J Pharm; 2014 Jul; 469(1):40-9. PubMed ID: 24732032
[TBL] [Abstract][Full Text] [Related]
23. Role of moisture on the physical stability of polymorphic olanzapine.
Paisana MC; Wahl MA; Pinto JF
Int J Pharm; 2016 Jul; 509(1-2):135-148. PubMed ID: 27234701
[TBL] [Abstract][Full Text] [Related]
24. Solid state characterization of the anti-HIV drug TMC114: interconversion of amorphous TMC114, TMC114 ethanolate and hydrate.
Van Gyseghem E; Stokbroekx S; de Armas HN; Dickens J; Vanstockem M; Baert L; Rosier J; Schueller L; Van den Mooter G
Eur J Pharm Sci; 2009 Dec; 38(5):489-97. PubMed ID: 19782132
[TBL] [Abstract][Full Text] [Related]
25. Manipulating theophylline monohydrate formation during high-shear wet granulation through improved understanding of the role of pharmaceutical excipients.
Wikström H; Carroll WJ; Taylor LS
Pharm Res; 2008 Apr; 25(4):923-35. PubMed ID: 17896097
[TBL] [Abstract][Full Text] [Related]
26. Screening for pharmaceutical cocrystal hydrates via neat and liquid-assisted grinding.
Karki S; Friscić T; Jones W; Motherwell WD
Mol Pharm; 2007; 4(3):347-54. PubMed ID: 17497885
[TBL] [Abstract][Full Text] [Related]
27. Characterization and monitoring of pseudo-polymorphs in manufacturing process by NIR.
Kamada K; Yoshimura S; Murata M; Murata H; Nagai H; Ushio H; Terada K
Int J Pharm; 2009 Feb; 368(1-2):103-8. PubMed ID: 19007870
[TBL] [Abstract][Full Text] [Related]
28. Drug hydrate systems and dehydration processes studied by terahertz pulsed spectroscopy.
Zeitler JA; Kogermann K; Rantanen J; Rades T; Taday PF; Pepper M; Aaltonen J; Strachan CJ
Int J Pharm; 2007 Apr; 334(1-2):78-84. PubMed ID: 17129691
[TBL] [Abstract][Full Text] [Related]
29. Processing-induced phase transitions of theophylline--implications on the dissolution of theophylline tablets.
Tantry JS; Tank J; Suryanarayanan R
J Pharm Sci; 2007 May; 96(5):1434-44. PubMed ID: 17455350
[TBL] [Abstract][Full Text] [Related]
30. Characterization of four crystal polymorphs and a monohydrate of s-bupivacaine hydrochloride (levobupivacaine hydrochloride).
Niederwanger V; Gozzo F; Griesser UJ
J Pharm Sci; 2009 Mar; 98(3):1064-74. PubMed ID: 18729201
[TBL] [Abstract][Full Text] [Related]
31. Solvent influences on metastable polymorph lifetimes: real-time interconversions using energy dispersive X-ray diffractometry.
DeMatos LL; Williams AC; Booth SW; Petts CR; Taylor DJ; Blagden N
J Pharm Sci; 2007 May; 96(5):1069-78. PubMed ID: 17455330
[TBL] [Abstract][Full Text] [Related]
32. Following the surface response of caffeine cocrystals to controlled humidity storage by atomic force microscopy.
Cassidy AM; Gardner CE; Jones W
Int J Pharm; 2009 Sep; 379(1):59-66. PubMed ID: 19539735
[TBL] [Abstract][Full Text] [Related]
33. Changes in the solid state of anhydrous and hydrated forms of sodium naproxen under different grinding and environmental conditions: Evidence of the formation of new hydrated forms.
Censi R; Rascioni R; Di Martino P
Eur J Pharm Biopharm; 2015 May; 92():192-203. PubMed ID: 25796350
[TBL] [Abstract][Full Text] [Related]
34. Solubility and stability of anhydrate/hydrate in solvent mixtures.
Qu H; Louhi-Kultanen M; Kallas J
Int J Pharm; 2006 Sep; 321(1-2):101-7. PubMed ID: 16784825
[TBL] [Abstract][Full Text] [Related]
35. Phase transformations of amlodipine besylate solid forms.
Koradia V; de Lemos AF; Allesø M; de Diego HL; Ringkjøbing-Elema M; Müllertz A; Rantanen J
J Pharm Sci; 2011 Jul; 100(7):2896-910. PubMed ID: 21344410
[TBL] [Abstract][Full Text] [Related]
36. Crystal structure and physicochemical characterization of ambazone monohydrate, anhydrous, and acetate salt solvate.
Muresan-Pop M; Braga D; Pop MM; Borodi G; Kacso I; Maini L
J Pharm Sci; 2014 Nov; 103(11):3594-3601. PubMed ID: 25187325
[TBL] [Abstract][Full Text] [Related]
37. Crystalline phase transition of ezetimibe in final product, after packing, promoted by the humidity of excipients: Monitoring and quantification by Raman spectroscopy.
Farias MADS; Soares FLF; Carneiro RL
J Pharm Biomed Anal; 2016 Mar; 121():209-214. PubMed ID: 26812479
[TBL] [Abstract][Full Text] [Related]
38. Physical characterization of nedocromil sodium hydrates.
Khankari R; Chen L; Grant DJ
J Pharm Sci; 1998 Sep; 87(9):1052-61. PubMed ID: 9724554
[TBL] [Abstract][Full Text] [Related]
39. Application of slurry bridging experiments at controlled water activities to predict the solid-state conversion between anhydrous and hydrated forms using theophylline as a model drug.
Ticehurst MD; Storey RA; Watt C
Int J Pharm; 2002 Oct; 247(1-2):1-10. PubMed ID: 12429480
[TBL] [Abstract][Full Text] [Related]
40. New technology for the investigation of water vapor sorption-induced crystallographic form transformations of chemical compounds: a water vapor sorption gravimetry-dispersive Raman spectroscopy coupling.
Feth MP; Jurascheck J; Spitzenberg M; Dillenz J; Bertele G; Stark H
J Pharm Sci; 2011 Mar; 100(3):1080-92. PubMed ID: 20740677
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
